Next 10 |
home / stock / neon:cc / neon:cc news
Toronto, Ontario--(Newsfile Corp. - le 13 juin/June 2023) - The common shares of Lancaster Resources Inc. (LCR) previously listed as NeonMind Biosciences Inc. (NEON) have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading...
Overview Psychedelics have taken center stage as an emerging treatment for mental health and behavioral disorders. Major research institutes such as John Hopkins and biotechnology companies have generated promising clinical data on the efficacy and safety of treatm...
Engages Thrive Health, a Leading Digital Patient Care Platform to Streamline Care Programs and Data Collection OAKVILLE, ON / ACCESSWIRE / April 21, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBD)(FRA:6UF) (" NeonMind '' or the " Company "), announced today it has advanced it...
Initiates Medical Adoption Program with Impetus Digital, a Leading Healthcare Platform for Virtual Medical Education OAKVILLE, ON / ACCESSWIRE / April 19, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBD)(FRA:6UF) (" NeonMind '' or the " Company "), an integrated drug development...
Toronto, Ontario--(Newsfile Corp. - le 14 avril/April 2022) - NeonMind Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every four (4) pre-consolidated common shares. As a result, the outst...
Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 / NeonMind Biosciences Inc. ( CSE:NEON ) ( OTCQB:NMDBF ) ( FRA:6UF ) (" NeonMind '' or the " Co...
Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge in demand for alternative options to traditional mental health support have fueled...
The world may be a step closer to successfully treating obesity with psilocybin. That's because psilocybin activates serotonin receptors, or "nature's own appetite suppressant," as noted by Psychology Today. "This powerful brain chemical curbs cravings and shuts off appetite. It makes you f...
To Deliver Low Dose Intravenous Ketamine for Mood and Anxiety Disorders, a Recommended Treatment by Canadian Guidelines, Upon Clinic Licensing OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences Inc. ( CSE:NEON )( OTCQB:NMDBF )( FRA:6UF ) (" NeonMind '' or the " Company ")...
Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002 OAKVILLE, ON / ACCESSWIRE / March 23, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) (" NeonMind '' or the " Company "), an integ...
News, Short Squeeze, Breakout and More Instantly...
Neonmind Biosciences Inc Company Name:
NEON:CC Stock Symbol:
CNQC Market:
Toronto, Ontario--(Newsfile Corp. - le 13 juin/June 2023) - The common shares of Lancaster Resources Inc. (LCR) previously listed as NeonMind Biosciences Inc. (NEON) have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading...
Overview Psychedelics have taken center stage as an emerging treatment for mental health and behavioral disorders. Major research institutes such as John Hopkins and biotechnology companies have generated promising clinical data on the efficacy and safety of treatm...
Engages Thrive Health, a Leading Digital Patient Care Platform to Streamline Care Programs and Data Collection OAKVILLE, ON / ACCESSWIRE / April 21, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBD)(FRA:6UF) (" NeonMind '' or the " Company "), announced today it has advanced it...